MedPath
HSA Approval

AXCEL DEXCHLORPHENIRAMINE FORTE SYRUP 2 mg/5 ml

SIN10542P

AXCEL DEXCHLORPHENIRAMINE FORTE SYRUP 2 mg/5 ml

AXCEL DEXCHLORPHENIRAMINE FORTE SYRUP 2 mg/5 ml

December 11, 1998

KOTRA PHARMA MARKETING

KOTRA PHARMA MARKETING

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantKOTRA PHARMA MARKETING
Licence HolderKOTRA PHARMA MARKETING

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

R06AB02

dexchlorpheniramine

Manufacturer Information

KOTRA PHARMA MARKETING

KOTRA PHARMA (M) SDN BHD

Active Ingredients

DEXCHLORPHENIRAMINE MALEATE

2 mg/5 ml

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AXCEL DEXCHLORPHENIRAMINE FORTE SYRUP 2 mg/5 ml - HSA Approval | MedPath